CARPRIEVE TABS 20MG BLISTER PK 100 - NORBROOK LABS

NORBROOK LABS
NORBROOK LABS

CARPRIEVE TABS 20MG BLISTER PK 100
NORBROOK LABS

LEGAL CLASSIFICATION: POM-V 

THIS MEDICINE REQUIRES A PRESCRIPTION. 

This can be uploaded on this page or it can be sent to mail@vets4u.uk.   

We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes. 

A link the the Medicine SPC on the VMD Product database can be found here: VMD Product Database

 A link the product Information can be found on the NOAH Compendium here: NOAH Data sheets

£0.00
£23.23
Earn0
reward points
Add To Your Wishlist

Oh No! This product is out of stock. Would you like to know when it's avaliable again?

  • Dosage and Administration

    DOSAGE AND ADMINISTRATION

    Amounts to be administered and administration route
    For oral administration.
    An initial dose of 2 to 4 mg carprofen/kg bodyweight/day is recommended to be given in 2 equally divided doses. The dose may be reduced to 2 mg carprofen/kg bodyweight/day administered as a single daily dose after 7 days, subject to clinical response.
    Duration of treatment will be dependent upon the response seen. Long term treatment should be under regular veterinary supervision.
    To extend analgesic cover post-operatively, parenteral administration of carprofen, may be followed with Carprieve Tablets.
  • Contra-Indications , Warnings

    CONTRA-INDICATIONS, WARNINGS, ETC

    The use of Carprieve Tablets is contraindicated in the cat, and the inadvertent administration of oral carprofen tablets may induce life-threatening conditions in this species.
    Do not exceed the stated dose.
    Do not administer NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects.
    Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia or hypersensitivity to the product.
    In the absence of any specific studies in pregnant bitches such use is not indicated.
    Special Warnings for each target species
    Use in dogs less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided, such dogs may require a reduced dosage and careful clinical management.
    Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
    NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated.
    Special precautions for use
    Special precautions for use in animals
    None.
    Special precautions to be taken by the person administering the veterinary medicinal product to animals
    None.
    Adverse reactions (frequency and seriousness)
    None.
    Use during pregnancy, lactation or lay
    In the absence of any specific studies in pregnant bitches such use is not indicated.
    Interaction with other medicinal products and other forms of interaction
    Do not administer NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects.
    Concurrent administration of potential nephrotoxic drugs should be avoided.
    Amounts to be administered and administration route
    For oral administration.
    An initial dose of 2 to 4 mg carprofen/kg bodyweight/day is recommended to be given in 2 equally divided doses. The dose may be reduced to 2 mg carprofen/kg bodyweight/day administered as a single daily dose after 7 days, subject to clinical response.
    Duration of treatment will be dependent upon the response seen. Long term treatment should be under regular veterinary supervision.
    To extend analgesic cover post-operatively, parenteral administration of carprofen, may be followed with Carprieve Tablets.
    Overdose (symptoms, emergency procedures, antidotes), if necessary
    Not applicable.
    Withdrawal period
    Not applicable.


    PACKAGING QUANTITIES

    Carprieve Tablets are supplied in:
    Polypropylene Snap Secure Tubs, containing 100 tablets, sealed with a white Polyethylene Snap Secure Cap.
    Alu/Alu blister strips of 2 x 5 tablets.
  • Further Info

    FURTHER INFORMATION

    List of excipients
    •Microcrystalline cellulose
    •Lactose monohydrate
    •Croscarmellose sodium
    •Poly-vinyl pyrrolidone K 30
    •Sodium laurilsulfate
    •Magnesium stearate
    •Purified water
    Shelf life
    Tubs: 36 months
    Blister strips: 24 months
    Special precautions for storage
    Do not store above 25°C.
    Store in a dry place.
    Protect from light.
    Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
    Any unused product or waste material should be disposed of in accordance with national requirements.

    MARKETING AUTHORISATION NUMBER

    Vm 02000/4220 


    GTIN (GLOBAL TRADE ITEM NO)

    GTIN description:Carprieve 20mg (100 Pack)
    GTIN:5023534008286
    GTIN description:Carprieve 20mg (100 Tablets)
    GTIN:5023534008279

Ask us a question